scholarly article | Q13442814 |
P50 | author | Andre Willasch | Q42861987 |
P2093 | author name string | R Handgretinger | |
G Henze | |||
T Klingebiel | |||
P Bader | |||
A von Stackelberg | |||
C Eckert | |||
B Kremens | |||
H Kreyenberg | |||
M Reising | |||
Y Yarkin | |||
P2860 | cites work | Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. | Q31099184 |
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. | Q35606345 | ||
Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: inv | Q38328321 | ||
Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia | Q44505579 | ||
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leu | Q53221286 | ||
Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia | Q61851837 | ||
Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring | Q73720153 | ||
Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation | Q77647316 | ||
Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease | Q77768046 | ||
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia | Q80292597 | ||
P433 | issue | 7 | |
P921 | main subject | lymphoblastic leukemia | Q18553852 |
P304 | page(s) | 1355-1358 | |
P577 | publication date | 2009-04-09 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation | |
P478 | volume | 23 |
Q41781135 | Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia. |
Q43014298 | NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All |
Search more.